What was filed
Jagsonpal Pharmaceuticals informed the exchanges that it has completed part of a previously announced acquisition of Aequitas Healthcare Private Limited. The filing refers back to an earlier letter dated 29 June 2026, in which the company had disclosed its intention to acquire an equity stake in Aequitas. This update confirms that a portion of that transaction has now closed.
From proposal to subsidiary
Of the 85% stake the company had proposed to acquire, it has now completed the purchase of a majority holding. As a result, per the filing, Aequitas Healthcare has become a subsidiary of Jagsonpal Pharmaceuticals. The filing does not disclose the consideration paid, Aequitas's business or financials, or the timeline for acquiring the remaining stake — those details are not part of this intimation.